N/A N=259 Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2)
Severe Hypoglycemia
Primary: Self-reported Severe Hypoglycemia — 99; 99; 19; 13 Participants — p=0.27
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=4 Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study
Diabetes
Primary: Peak Epinephrine Levels — 609 pg/mL
Phase 2 N=29 Naltrexone and Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes · Hypoglycemia Unawareness
Primary: Cerebral Blood Flow — 1.7; 1.3 percentage of signal intensity change
Phase 2 N=25 Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia
Acquired Hyperinsulinemic Hypoglycemia
Primary: Diurnal Level 2 Hypoglycemia Events (ADA, <54 mg/dL) as Measured by CGM in Patients With Severe Hyperinsulinemic Hypoglycemia (HH) — 5.2; 5.2; 2.7; 2.1 events per 14…
Phase 2 N=30 Naloxone, Hypoglycemia and Exercise
Diabetes Mellitus, Type 1
Primary: Change in Symptom Score — 25; 21 score on a scale
N/A N=50 A Cognitive Behavioral Therapy (CBT) Intervention to Reduce Fear of Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus
Primary: Fear of Hypoglycemia — 54.3; 58.7; 35.29; 49.0 units on a scale
Early Phase 1 N=9 Adrenergic System in Islet Transplantation
Type1diabetes · Hypoglycemia · Hypoglycemia Unawareness
Primary: C-PEPTIDE Suppression During Hyperinsulinemia Euglycemia. — 0.51; 0.56; 0.59 ng/mL
Early Phase 1 N=33 Mechanisms for Restoration of Hypoglycemia Awareness
Type1 Diabetes Mellitus
Primary: Brain Glucose Levels — 2.45; 2.16 Mmol/L — p=0.907
N/A N=83 The Effectiveness of Multimedia Education on Hypoglycemic Management.
Type2diabetes · Hypoglycemia
Primary: The Score of Hypoglycemia Knowledge — 5.8; 4.8 score on a scale
Phase 1 N=171 Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Primary: The Primary Endpoint is the Occurrence of Dose Limiting Toxicity (DLT). — 0; 0 participants
N/A N=10 Hybrid Closed Loop Insulin Delivery System in Hypoglycemia
Type1diabetes · Hypoglycemia Unawareness · Nocturnal Hypoglycemia
Primary: Endogenous Glucose Production — .66 [mg/(kgxmin)]
N/A N=7 Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia
Postprandial Hypoglycemia
Primary: Mean Plasma Glucose Area Under the Curve (AUC 0-3h) — 22,192.5; 25,207.1; 21,715.9 mg*min/dl
Early Phase 1 N=20 Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4
Type 2 Diabetes
Primary: Percent Changes in Endothelial Function as Measured by Flow Mediated Dilation by 2D Doppler Ultrasound on Day 2 — 2; 7 percentage of change
Phase 3 N=125 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes
Type 1 Diabetes Mellitus
Primary: Event Rate of "All Hypoglycemia" Defined as the Total Number of Episodes Divided by the Total Duration of the On-treatment Period in Years (Events Per Patient-year)…
N/A N=1,439 Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery
Cardiac Surgery
Primary: Any Major Morbidity/30-day Mortality — 46; 82 Participants — p=0.0043